Biotech

Theravance Biopharma to Report Second Quarter 2016 Financial Results on August 8, 2016

DUBLIN, IRELAND: ...

ANGLE plc: Use of Parsortix in GANNET53 Drug Trial

GUILDFORD, UNITED KINGDOM: ...

ANGLE plc ("the Company"): Initiation of 200 Patient United States Ovarian Cancer Study

GUILDFORD, UNITED KINGDOM: Leading United States Cancer Centre Recruiting Patients; Complements Recently Started European Study Also in Ovarian Cancer ...

VBI Vaccines Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer

CAMBRIDGE, MASSACHUSETTS: ...

RepliCel''s Cell Therapy for Pattern Baldness Proceeds to Clinical Trial Launch in Japan

VANCOUVER, BRITISH COLUMBIA: ...

VBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus

CAMBRIDGE, MASSACHUSETTS: ...

Arch Biopartners Forms Clinical and Medical Advisory Board for AB569

TORONTO, ONTARIO: ...

Angle PLC: Notice of Results

GUILDFORD, SURREY: ...

True Nature Holding, Inc. Receives Georgia Board of Pharmacy Approval on Integrity Acquistion, Updates Acquisition Timing and Appoints Executive

ATLANTA, GA: Leadership Consolidated Under Jim Driscoll, CEO ...

Calyx Announces New Management Appointments

VANCOUVER, BRITISH COLUMBIA: ...